Sandeep Juneja joined the TB Alliance in May 2018. As Senior Vice President of Market Access, he is responsible for leading the TB Alliance’s work in the design and implementation of market interventions and access strategies for rapid adoption and uptake of new TB regimens globally and in countries most affected with tuberculosis.

Mr. Juneja is passionate about shortening the gap between R&D and market availability of novel medicines, especially in developing countries. Prior to joining TB Alliance, Mr. Juneja worked as the head of business development at the Medicines Patent Pool, Geneva where he forged alliances with pharmaceutical industry, research institutes and other public health stakeholders to increase access to TB, HIV, and HCV medicines. Previously, he spent 17 years in the pharmaceutical industry in diverse roles including marketing, M&A, investor relations and was responsible for building an HIV and Malaria franchise in developing countries that resulted in access to HIV medicines in 60+ countries and development of an NCE for Malaria. He has served on several committees and panels related to Access to Medicines, such as the Advisory Board of the Medicines4All Institute, Steering Committee on Universal Access, Global Fund Procurement Advisory Panel, and Global Fund Market Dynamics Advisory Group.

An engineer by training, Mr. Juneja has a bachelor’s degree in technology from the Indian Institute of Technology and holds an MBA in International Business from the Indian Institute of Foreign Trade.